FundVerifiedPro
LongeVC
Venture capital firm investing in longevity and biosecurity science; backed HelixNano and its spinout Red Queen Bio.
LongeVC is a venture capital firm investing in longevity and biosecurity science. It backed HelixNano, an mRNA-therapeutics company, and later participated in the seed round of HelixNano's spinout, Red Queen Bio.
Overview
- Firm
- LongeVC
- Headquarters
- United States
- Founded
- 0
- AUM
- Stages
- Thesis
Partners0
No linked records yet.
Sources & citations1
Each claim links to its underlying source. Confidence reflects how directly the source supports the claim.
- 1
LongeVC portfolio company Red Queen Bio, a HelixNano spinout, raised a $15 million seed round led by OpenAI.
LongeVC: LongeVC Portfolio Company Red Queen Bio Raises $15M to Strengthen AI-Driven BiosecurityVerified2025-11-14